[{"Assets_0_FY_USD":71670000.0,"CommonStockSharesOutstanding_0_FY_shares":74512048.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-21907000.0,"NetIncomeLoss_1_FY_USD":-34428000.0,"NetIncomeLoss_4_FY_USD":-53171000.0,"StockholdersEquity_0_FY_USD":11687000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_FY_USD":715000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_4_FY_USD":2961000.0,"Ticker":"EYPT","CIK":"1314102","name":"EYEPOINT PHARMACEUTICALS, INC.","OfficialName":"EyePoint Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20180630","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"408871503.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180918"}]